1.      Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28(5):488–496. doi: 10.1097/QCO.0000000000000188.

2.      Aggarwal R, Jameel S. Hepatitis E. Hepatology. 2011;54(6):2218-2226. doi: 10.1002/hep.24674.

3.      Bhattarai N, Stapleton JT. GB virus C: the good boy virus? Trends Microbiol. 2012;20(3):124–130. doi: 10.1016/j.tim.2012.01.004.

4.      Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J. 2008;27(5):425-430. doi: 10.1097/INF.0b013e3181646d95.

5.      Da BL, Heller T, Koh C. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterol Rep. 2019;7(4):231–245. doi: 10.1093/gastro/goz023.

6.      de la Serna-Higuera C, Gonzalez-Garcia M, Milicua JM, et al. [Cytomegalovirus granulomatous hepatitis in an immunocompetent patient]. Gastroenterol Hepatol. 1999;22(5):230-231.

7.      Dwivedi M, Manocha H, Tiwari S, et al. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr Infect Dis J. 2009;28(7):649-650. doi: 10.1097/INF.0b013e318198d05c.

8.      El-Kamary SS, Ravi Jhaveri R. Hepatitis. In: Cherry JD, Kaplan SL, Harrison GJ, Katrina Loh and Vahe Badalyan eds. Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 9th ed. Philadelphia, PA: Elsevier; 2025: 485-492. 

9.      Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017;64(1):154–168. doi: 10.1097/MPG.0000000000001334.

10.  Feldman S, Crout JD, Andrew ME. Incidence and natural history of chemically defined varicella-zoster virus hepatitis in children and adolescents. Scand J Infect Dis. 1997;29(1):33-36. doi: 10.3109/00365549709008661.

11.  Fingeroth JD. Herpesvirus infection of the liver. Infect Dis Clin North Am. 2000;14(3):689-719. doi: 10.1016/s0891-5520(05)70127-6.

12.  Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338(24):1741-1751. doi: 10.1056/NEJM199806113382407.

13.  Franco E, Meleleo C, Serino L, et al. Hepatitis A: epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68–73. doi: 10.4254/wjh.v4.i3.68.

14.  Gu X, Li X, An X, Yang S, Wu S, Yang X, et al. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay. J Clin Lab Anal. 2020;34(7):e23391. doi: 10.1002/jcla.23391.

15.  Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet Lond Engl. 2011;378(9785):73–85. doi: 10.1016/S0140-6736(10)61931-9.

16.  Karnsakul W, Schwarz KB. Hepatitis B and C. Pediatr Clin North Am. 2017;64(3):641– 658. doi: 10.1016/j.pcl.2017.01.007.

17.  Katelaris PH, Jones DB. Fulminant hepatic failure. Med Clin North Am. 1989;73(4):955-970. doi: 10.1016/s0025-7125(16)30647-2.

18.  Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014;160(12):828-835. doi: 10.7326/M13-2529.

19.  Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41-52. doi: 10.1056/NEJM200107053450107.

20.  Loh K, Badalyan V. Acute Hepatitis. In: Long SS, Prober CG, Fischer M, Kimberlin DW, eds. Principles and Practice of Pediatric Infectious Diseases, 6th ed. Philadelphia, PA: Elsevier; 2023: 419-423.

21.  McGoogan KE, Haafiz AB, Gonzalez Peralta RP. Herpes simplex virus hepatitis in infants: clinical outcomes and correlates of disease severity. J Pediatr. 2011;159(4):608-611. doi: 10.1016/j.jpeds.2011.03.017.

22.  Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39(2):115–128. doi: 10.1097/00005176-200408000-00001.

23.  Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis. 1998;27(5):1194-1200. doi: 10.1086/514978.

24.  Murray KF, Hadzic N, Wirth S, et al. Drug-related hepatotoxicity and acute liver failure. J Pediatr Gastroenterol Nutr. 2008;47(4):395-405. doi: 10.1097/MPG.0b013e3181709464.

25.  Narkewicz MR, Cabrera R, Gonzalez-Peralta RP. The “C” of viral hepatitis in children. Semin Liver Dis. 2007;27(3):295-311. doi: 10.1055/s-2007-985074.

26.  Nel E, Sokol RJ, Comparcola D, et al. Viral hepatitis in children. J Pediatr Gastroenterol Nutr. 2012;55(5):500–505. doi: 10.1097/MPG.0b013e318272aee7.

27.  Ragusa R, Corsaro LS, Frazzetto E, et al. Hepatitis C virus infection in children and pregnant women: an Updated review of the Literature on screening and treatments. AJP Rep. 2020;10(1):e121–e127. doi: 10.1055/s-0040-1709185.

28.  Rentz AC, Libbey JE, Fujinami RS, et al. Investigation of treatment failure in neonatal echovirus 7 infection. Pediatr Infect Dis J. 2006;25(3):259-262. doi: 10.1097/01.inf.0000202071.38484.93.

29.  Santos JL, Choquette M, Bezerra JA. Cholestatic liver disease in children. Curr Gastroenterol Rep. 2010;12(1):30–39. doi: 10.1007/s11894-009-0081-8.

30.  Seth A, Sherman KE. Hepatitis E: What We Think We Know. Clin Liver Dis. 2020;15 (Suppl 1):S37–S44. doi: 10.1002/cld.858.

31.  Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. doi: 10.1002/hep.29800.

32.  Teshale E, Ward JW. Making hepatitis E a vaccine-preventable disease. N Engl J Med. 2015;372(10):899–901. doi: 10.1056/NEJMp1415240.

33.  Webster DP, Klenerman P, Dusheiko GM. Hepatitis C. Lancet Lond Engl. 2015;385(9973):1124–1135. doi: 10.1016/S0140-6736(14)62401-6.